Phase II Trial PD-L1/PD-1 Blockade Avelumab (MSB0010718C) With Chemoradiotherapy for Locally Advanced Resectable Rectal Cancer
Latest Information Update: 11 Dec 2023
At a glance
- Drugs Avelumab (Primary) ; Capecitabine; Fluorouracil
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms AveRec
- 24 Oct 2023 Results (n=37) presented at the 48th European Society for Medical Oncology Congress.
- 06 Jun 2023 Interim Results presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 14 Mar 2023 Status changed from active, no longer recruiting to completed.